Actively Recruiting

Phase Not Applicable
Age: 1Year - 16Years
All Genders
NCT07206537

The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome

Led by Ain Shams University · Updated on 2025-10-03

60

Participants Needed

1

Research Sites

56 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Long-term glucocorticoids therapy is associated with various complications, including decreased bone strength (Glucocorticoid-induced osteoporosis) and an increased risk of fracture. Vitamin K2 has been recently deemed appreciable as a topic of research as it plays a pivotal role in maintenance of the bone strength, and it has been proved to have a positive impact on the bone metabolism. This study examines the impact of oral vitamin K2 supplementation on bone metabolism in pediatric patients with nephrotic syndrome on long-term steroid therapy, offering valuable therapeutic insights

CONDITIONS

Official Title

The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome

Who Can Participate

Age: 1Year - 16Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Nephrotic patients under 16 years of age of both genders who were treated with glucocorticoids for the first time
  • Glucocorticoid treatment started at 2 mg/kg/day prednisolone with gradual dose reduction
  • Patients have been on glucocorticoid therapy for more than 6 months
  • Patients have sufficient vitamin D levels of 30 ng/ml (75 nmol/L) or above
Not Eligible

You will not qualify if you...

  • Patients with impaired kidney functions
  • Non-compliant patients on medications or vitamin supplements
  • Diseases affecting fat-soluble vitamin absorption such as gallbladder or biliary disease, cystic fibrosis, celiac disease
  • History of vitamin K-related disorders like bleeding disorders or osteomalacia
  • History of bone fracture before the study
  • Any nephrotic syndrome with identified genetic causes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ain Shams University

Cairo, Egypt

Actively Recruiting

Loading map...

Research Team

N

Noha Saied Ibrahim, Teaching Assistant

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here